Holen Sie sich die Stockscreener-App
13.21
2.01%
0.26
Handel nachbörslich:
13.25
0.04
+0.30%
Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten
How to track smart money flows in MBX Biosciences Inc.July 2025 EndofMonth & Real-Time Market Sentiment Alerts - Newser
What to do if you’re stuck in MBX Biosciences Inc.July 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Can volume confirm reversal in MBX Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Volatility clustering patterns for MBX Biosciences Inc.July 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Applying big data sentiment scoring on MBX Biosciences Inc.Weekly Loss Report & Weekly High Return Forecasts - Newser
Can a trend reversal in MBX Biosciences Inc. lead to recovery2025 Top Decliners & Free Risk Controlled Daily Trade Plans - Newser
How to use a screener to detect MBX Biosciences Inc. breakoutsJuly 2025 Decliners & Target Return Focused Picks - Newser
MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Can trapped investors hope for a rebound in MBX Biosciences Inc. [2025 Trading Recap]Free Daily Stock Trend Watchlist - Newser
What makes MBX Biosciences Inc. stock price move sharplyHigh Return Consistency Watch - classian.co.kr
MBX Biosciences Triggers Bullish KDJ Golden Cross and Marubozu - AInvest
MBX Biosciences Inc. recovery potential after sell offSector Rotation Strategy for Smart Traders - Newser
Using economic indicators to assess MBX Biosciences Inc. potentialSector-Wise Equity Performance Trend Forecast - Newser
MBX Biosciences Reports Progress and Financial Stability - TipRanks
Tools to assess MBX Biosciences Inc.’s risk profileTriple Digit Gain Opportunity Watchlist - Newser
Technical signs of recovery in MBX Biosciences Inc.Free Reliable Investment Entry Point Signals - Newser
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Market Surge Signal for Swing Traders - Newser
What’s next for MBX Biosciences Inc. stock priceFree Low Volatility Stable Growth Picks - Newser
How does MBX Biosciences Inc. compare to its peers3x ROI Investment Watch - thegnnews.com
MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Mizuho - MarketBeat
Technical analysis overview for MBX Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
Is MBX Biosciences Inc. forming a reversal patternSwing Trade Picks with High Potential - Newser
MBX Biosciences Inc. Forms Bullish Flag — Upside AheadBreakout Entry Signal Confirmation Tool Used - beatles.ru
MBX Biosciences (NYSE:MBX) Research Coverage Started at Mizuho - Defense World
Mbx Biosciences (MBX) Q2 Loss Widens 22% - Nasdaq
MBX Biosciences Q2 revenue $224.9mln, cash to support operations into mid-2027. - AInvest
MBX Biosciences reports Q2 revenue, cash, and pipeline progress. - AInvest
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
MBX Biosciences Reveals Triple Clinical Trial Progress, Secures 2-Year Cash Runway With $224M - Stock Titan
How MBX Biosciences Inc. stock performs during market volatilitySmart Entry Signals for Active Traders - Newser
Mizuho Securities Initiates MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $38 - 富途牛牛
Analyst Upgrades and Initiations for Tuesday: Lionsgate Studios, MBX Biosciences, D-Wave Quantum, APA Corporation, and Quince Therapeutics - AInvest
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Mizuho initiates MBX Biosciences stock with Outperform rating on promising pipeline - Investing.com Canada
MBX Biosciences: Mizuho Initiates Coverage on Outperform with $38 PT - AInvest
Mizuho Initiates MBX Biosciences at Outperform - MarketScreener
MBX Biosciences initiated with an Outperform at Mizuho - TipRanks
RSI Crosses Above 30 for MBX Biosciences Inc. — Reversal in SightSector Rotation Based Trading Opportunities Identified - metal.it
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):